1Bonville CA, Easton A J, Rosenberg HF,et al. Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents. Journal of Virology, 2003, 77 : 1237 - 1244.
2Foulds KE, Rotte MJ, Seder RA, et al. IL-10 is required for optimal CD8 T Cell memory following listeria monocytogenes infection. J Immunol,2006,177:2565 - 2574.
3Berenson CS, Wrona CT, Grove LJ. et al. Impaired alveolar macrophage response to haemophilus antigens in chronic obstructive lung disease. Am J Respir Crit Care Med,2006,174:31 - 40.
4Kathleen D. Liu and Michael A. Matthay. Advances in critical care for the nephrologist : acute lung injury/ARDS. Clin J Am Soc Nephrol,2008,3:578 - 586.
5Juge-Aubry CE, Somm E, Chicheportiche R, et al. Regulatory effects of interleukin (IL) -1, interferon-β, and IL-4 on the production of IL-1 receptor antagonist by human adipose tissue. Clin Endocrinol Metab,2004,89:2652 - 2658.
6Portnoy J, Pan T, Dinarello CA, et al. Alveolar type II cells inhibit fibroblast proliferation: iole of IL-1. Am J Physiol Lung Cell Mol Physiol, 2006,290 : 307 - 316.
7Poree B, Kypriotou M, Chadjichristos C, et al. Interleukin-6 (IL- 6 ) and/or soluble IL-6 receptor down - regulation of human type Ⅱ collagen gene expression in articular chondroeytes requires a decrease of Sp1 · Sp3 ratio and of the binding activity of both factors to the COL2A1 Promoter. J Biol Chem,2008,283:4850 -4865.
8Frevert CW, Goodman RB, Kinsella MG, et al. Tissue-specific mechanisms control the retention of IL-8 in lungs and skin. J Immunol,2002,168:3550 - 3556.
9Das A, Boggaram V. Proteasome dysfunction inhibits surfactant protein gene expression in lung epithelial ceils: mechanism of inhibition of SP-B gene expression. Am J Physiol Lung Cell Mol Physiol, 2007,292 :L74 - L84.
10Fukuda N, Jayr C, Lazrak A,et al. Mechanisms of TNF-stimulation of amiloride-sensitive sodium transport across alveolar epithelium. Am J Physiol Lung Cell Mol Physiol,2001,280:1258 - 1265.
